De-extinction startup eyes $30B valuation
Colossal Biosciences, a de-extinction startup, eyes a $30B valuation in new funding talks—doubling its worth in a year.
Greylock caps fund at $1.5B despite ability to raise more
Greylock Ventures caps its 18th fund at $1.5B despite raising more. See why the VC firm decided against…
San Francisco mayor seeks stricter robotaxi rules
San Francisco mayor demands stricter robotaxi rules after Waymo vehicles block traffic, calling for statewide safety standards.
AI investment surge set to rebound
AI investment surge is poised for a rebound as venture capital shifts focus, with redistribution expected to balance…
Nolan slams AI as a Trojan horse
Christopher Nolan calls AI a 'Trojan horse' hiding real threats, sparking debate on artificial intelligence risks and public…
De-extinction startup eyes $30B valuation
Colossal Biosciences, a de-extinction startup, eyes a $30B valuation in new funding talks—doubling its worth in a year.